Devices › Device types
FDA product code MWI · class 2 · Cardiovascular
Monitor, physiological, patient (without arrhythmia detection or alarms): medical device reports filed with FDA
2,065 reports carry this product code, 2001–2026; 5 brands with a page.
- 2,065
- reports with this product code
- 0% of all MAUDE reports
- 546
- reports, 12 months to August 2026
- 125 in the 12 months before
- 91.1%
- classified as malfunction
- 62.3% across all reports
- 2.2%
- classified as death, as reported
- 0.9% across all reports
Product code MWI is FDA's classification for "Monitor, physiological, patient (without arrhythmia detection or alarms)" (cardiovascular panel), a class 2 device. 2,065 medical device reports carry this product code, 0% of the MAUDE database, from June 2001 to August 2026.
546 reports arrived in the 12 months to August 2026, up 337% from 125 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (91.1%), injury (5.6%) and death (2.2%). 5 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Rad-97 | 314 | 246 | 0.3% | 99.1% |
| Xper Flex Cardio Physiomonitoring System | 211 | 6 | 2.4% | 89.1% |
| Carescape | 3 | 2,289 | 0.1% | 99.4% |
| Radical-7 | 2 | 79 | 1.7% | 97.3% |
| IntelliVue Multi-Measurement Module X3 | 1 | 401 | 1.7% | 93.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Masimo - 15750 Alton Pkwy | 579 | 28% |
| Masimo - 40 Parker | 212 | 10.3% |
| Welch Allyn | 208 | 10.1% |
| Remote Diagnostic Technologies | 51 | 2.5% |
| Philips Medizin Systeme B Blingen | 40 | 1.9% |
| Masimo | 23 | 1.1% |
| Welch Allyn Protocol | 11 | 0.5% |
| Bayer Healthcare | 5 | 0.2% |
| Philips Healthcare | 5 | 0.2% |
| Ge Healthcare | 4 | 0.2% |
| Mindray Ds USA | 4 | 0.2% |
| Philips North America | 4 | 0.2% |
| Philips Medical Systems Nederland | 3 | 0.1% |
| Draeger Medical Systems | 2 | 0.1% |
| Bayer | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Incorrect measurementthe device measured wrongly | 249 | 12.1% |
| Unexpected shutdown | 242 | 11.7% |
| Device alarm system | 109 | 5.3% |
| No audible alarm | 99 | 4.8% |
| Sensing intermittently | 98 | 4.7% |
| High readingsreadings were too high | 90 | 4.4% |
| Display or visual feedback problem | 79 | 3.8% |
| Incorrect, inadequate or imprecise result or readings | 69 | 3.3% |
| Inappropriate or unexpected reset | 60 | 2.9% |
| Device operates differently than expectedthe device behaved unexpectedly | 53 | 2.6% |
| Failure to power up | 49 | 2.4% |
| Device displays incorrect message | 48 | 2.3% |
| Low readingsreadings were too low | 47 | 2.3% |
| Application program freezes or fails to launch | 45 | 2.2% |
| Insufficient device problem information | 43 | 2.1% |
| Breakthe device broke | 41 | 2% |
| Communication or transmission problemthe device could not communicate or transmit | 38 | 1.8% |
| Unable to obtain readings | 38 | 1.8% |
| Defective alarm | 37 | 1.8% |
| Sparking | 35 | 1.7% |
Questions about monitor, physiological, patient (without arrhythmia detection or alarms) reports
What is product code MWI?
FDA's classification code for "Monitor, physiological, patient (without arrhythmia detection or alarms)", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,065 reports through August 2026, 546 of them in the latest 12 months.
Which brands appear most often?
Rad-97 (314), Xper Flex Cardio Physiomonitoring System (211), Carescape (3), Radical-7 (2) and IntelliVue Multi-Measurement Module X3 (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.